Teva Pharmaceuticals
TEVA
TEVA
623 hedge funds and large institutions have $21.4B invested in Teva Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 132 funds opening new positions, 205 increasing their positions, 186 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 547 → 623 (+76)
10% more repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 186
2.6% more ownership
Funds ownership: 57.3% → 59.9% (+2.6%)
Holders
623
Holding in Top 10
37
Calls
$1.1B
Puts
$673M
Top Buyers
| 1 | +$339M | |
| 2 | +$179M | |
| 3 | +$146M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$132M |
| 5 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$119M |
Top Sellers
| 1 | -$417M | |
| 2 | -$264M | |
| 3 | -$160M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$152M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$122M |
